JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3376
PSQ Holdings
PSQH
$14.7M
| $2.03M | ﹤0.01% |
+13,333
| New | +$2.01M |
2023 Q1
0 quarters
|
|
3377
PUT
Enterprise Products Partners
EPD
$79.9B
| $2.02M | ﹤0.01% |
78,200
-549,000
| -88% | -$14.1M |
2021 Q2
7 quarters
|
|
3378
Manitowoc
MTW
$804M
| $2.02M | ﹤0.01% |
118,283
+24,044
| +26% | +$360K |
2015 Q3
30 quarters
|
|
3379
CALL
Coinbase
COIN
$47.4B
| $2.02M | ﹤0.01% |
+29,900
| New | +$1.79M |
2023 Q1
0 quarters
|
|
3380
PUT
TSMC
TSM
$2.46T
| $2.02M | ﹤0.01% |
21,700
-305,200
| -93% | -$27.4M |
2021 Q1
8 quarters
|
|
3381
CALL
Intuitive Surgical
ISRG
$145B
| $2.02M | ﹤0.01% |
7,900
-40,600
| -84% | -$10M |
2017 Q2
23 quarters
|
|
3382
Sphere Entertainment
SPHR
$3.82B
| $2.02M | ﹤0.01% |
34,123
+6,505
| +24% | +$352K |
2020 Q2
11 quarters
|
|
|
FTCH
3383
CALL
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $2M | ﹤0.01% |
407,400
-221,300
| -35% | -$1.2M |
2022 Q3
2 quarters
|
|
3384
PUT
Riot Platforms
RIOT
$6.83B
| $2M | ﹤0.01% |
200,000
+197,300
| +7,307% | +$1.28M |
2022 Q1
4 quarters
|
|
|
SASR
3385
DELISTED
Sandy Spring Bancorp Inc
SASR
| $2M | ﹤0.01% |
76,901
-47,350
| -38% | -$1.52M |
2015 Q4
29 quarters
|
|
3386
QuantumScape Corp
QS
$2.77B
| $2M | ﹤0.01% |
243,976
+74,940
| +44% | +$608K |
2020 Q3
10 quarters
|
|
3387
Invesco Biotechnology & Genome ETF
PBE
$415M
| $2M | ﹤0.01% |
31,778
+3,882
| +14% | +$250K |
2022 Q4
1 quarter
|
|
|
GBIO
3388
DELISTED
Generation Bio
GBIO
| $1.99M | ﹤0.01% |
46,385
+271
| +0.6% | +$13.1K |
2020 Q2
11 quarters
|
|
3389
Atlanta Braves Holdings Series A
BATRA
$3.72B
| $1.99M | ﹤0.01% |
57,631
-86,797
| -60% | -$2.97M |
2016 Q2
27 quarters
|
|
3390
Black Stone Minerals
BSM
$3.11B
| $1.99M | ﹤0.01% |
126,731
-1,025,930
| -89% | -$16.1M |
2015 Q2
31 quarters
|
|
3391
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.13B
| $1.99M | ﹤0.01% |
83,710
+62,544
| +295% | +$1.47M |
2020 Q1
12 quarters
|
|
3392
Sonic Automotive
SAH
$1.91B
| $1.99M | ﹤0.01% |
36,583
-127,796
| -78% | -$6.88M |
2016 Q2
27 quarters
|
|
3393
ARK Blockchain & Fintech Innovation ETF
ARKF
$838M
| $1.98M | ﹤0.01% |
105,442
+28,400
| +37% | +$501K |
2020 Q4
9 quarters
|
|
|
AGS
3394
DELISTED
PlayAGS
AGS
| $1.98M | ﹤0.01% |
277,575
+273,268
| +6,345% | +$1.7M |
2018 Q1
20 quarters
|
|
3395
Fidelity High Dividend ETF
FDVV
$10.2B
| $1.97M | ﹤0.01% |
51,717
+20,079
| +63% | +$771K |
2019 Q4
13 quarters
|
|
3396
Teekay Tankers
TNK
$3.57B
| $1.97M | ﹤0.01% |
45,848
+32,353
| +240% | +$1.2M |
2021 Q2
7 quarters
|
|
|
ETWO
3397
DELISTED
E2open Parent Holdings
ETWO
| $1.97M | ﹤0.01% |
337,772
+38,353
| +13% | +$232K |
2021 Q2
7 quarters
|
|
|
SCU
3398
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $1.96M | ﹤0.01% |
227,410
-4,832
| -2% | -$43.4K |
2013 Q2
39 quarters
|
|
|
SWI
3399
DELISTED
SolarWinds Corporation Common Stock
SWI
| $1.96M | ﹤0.01% |
227,467
+30,364
| +15% | +$283K |
2019 Q1
16 quarters
|
|
3400
Korea Electric Power
KEP
$14.2B
| $1.96M | ﹤0.01% |
281,824
-51,240
| -15% | -$379K |
2015 Q4
29 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.